Imaging of Aβ plaques in the brain of Alzheimer's disease

International Congress Series

Volumn 1264, Issue C, 2004, Pages 3-9

  Kung, H F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Beta amyloid; In vitro binding; PET imaging; Senile plaque

Indexed keywords

EID: 84891014245     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2004.01.055     Document Type: Article

References (28)

1. Lee, V.M., Trojanowski, J.Q., Neurodegenerative tauopathies: human disease and transgenic mouse models. Neuron 24 (1999), 507–510.
2. Hardy, J., Selkoe, D.J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002), 353–356.
3. Rosenberg, R.N., Explaining the cause of the amyloid burden in Alzheimer disease. Arch. Neurol. 59 (2002), 1367–1368.
4. Barrio, J.R., et al. PET imaging of tangles and plaques in Alzheimer's disease. J. Nucl. Med. 40 (1999), 70–71.
5. Barrio, J.R., et al. PET imaging of tangles and plaques in Alzheimer's disease with a highly hydrophobic probe. J. Labelled Compd. Radiopharm., 42(Suppl. 1), 1999, S194.
6. 18F]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile. Neuroscience 117 (2003), 723–730.
7. Shoghi-Jadid, K., et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease: binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer disease. Am. J. Geriatr. Psychiatry 10 (2002), 24–35.
8. Agdeppa, E.D., et al. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for β-amyloid plaques in Alzheimer's disease. J. Neurosci., 21, 2001, RC189.
9. 99mTc-N2S2 conjugates of chrysamine G, potential probes for the beta-amyloid protein of Alzheimer's disease. J. Labelled Compd. Radiopharm. 42 (1999), 309–324.
10. Zhen, W., et al. Synthesis and amyloid binding properties of rhenium complexes: preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain. J. Med. Chem. 42 (1999), 2805–2815.
11. 123I labeled Congo Red via solid phase organic chemistry. J. Labelled Compd. Radiopharm. 44 (2001), 921–929.
12. Styren, S.D., et al. X-34, a fluorescent derivative of Congo Red: a novel histochemical stain for Alzheimer's disease pathology. J. Histochem. Cytochem. 48 (2000), 1223–1232.
13. Mathis, C.A., et al. In vivo evaluation and imaging of a lipophilic derivative of Congo Red for amyloid assessment. J. Nucl. Med., 42, 2001, 252P (abstract).
14. Lee, C.-W., et al. Isomerization of (Z,Z) to (E,E)1-bromo-2,5-bis-(3-hydroxy carbonyl-4-hydroxy)styrylbenzene in strong base: probes for amyloid plaques in the brain. J. Med. Chem. 44 (2001), 2270–2275.
15. Skovronsky, D.M., et al. In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 7609–7614.
16. Zhuang, Z.-P., et al. Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates. J. Med. Chem. 44 (2001), 1905–1914.
17. Wang, Y., et al. Synthesis and evaluation of a radioiodinated benzothiazole derivative as a radiologand for in vivo quantitation of β-amyloid deposits in aging and Alzheimer's disease. J. Labelled Compd. Radiopharm. 44 (2001), S239–S241.
18. Klunk, W.E., et al. Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci. 69 (2001), 1471–1484.
19. Mathis, C.A., et al. A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorg. Med. Chem. Lett. 12 (2002), 295–298.
20. 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J. Med. Chem. 46 (2003), 2740–2754.
21. Engler, H., et al. First human study with a benzothiazole amyloid-imaging agent in Alzheimer's disease and control subjects. Neurobiol. Aging, 23, 2002, S429 (abstract 1568).
22. Zhuang, Z.-P., et al. IBOX(2-(4′-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain. Nucl. Med. Biol. 28 (2001), 887–894.
23. Klunk, W.E., et al. The binding of 2-(4′-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J. Neurosci. 23 (2003), 2086–2092.
24. Ono, M., et al. Benzofuran derivatives as Ab-aggregate-specific imaging agents for Alzheimer's disease. Nucl. Med. Biol. 29 (2002), 633–642.
25. Zhuang, Z.P., et al. Structure-activity relationship of imidazo[1,2−a]pyridines as ligands for detecting beta-amyloid plaques in the brain. J. Med. Chem. 46 (2003), 237–243.
26. Kung, M.P., et al. IMPY: An improved thioflavin-T derivative for in vivo Labeling of β-amyloid plaques. Brain Res. 956 (2002), 202–210.
27. Kung, H.F., et al. Novel stilbenes as probes for amyloid plaques. J. Am. Chem. Soc. 123 (2001), 12740–12741.
28. 11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease. Nucl. Med. Biol. 30 (2003), 565–571.